Abstract
Breaking a bottleneck for on-target toxicity: A mutant-selective PI3K�� inhibitor finally comes
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have